Get started
Emcure Pharmaceuticals LimitedEmcure Pharmaceuticals LimitedEmcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

EMCURE chart


Full chart

EMCURE upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪251.18 B‬ INR
Dividend yield (indicated)
0.23%
Price to earnings Ratio (TTM)
33.70
Basic EPS (TTM)
39.35 INR
Net income (FY)
‪6.81 B‬ INR
Revenue (FY)
‪78.19 B‬ INR
Shares float
‪25.90 M‬
Beta (1Y)
1.33

Employees


Employees (FY)
‪6.73 K‬
Revenue / Employee (1Y)
‪11.62 M‬ INR
Net income / Employee (1Y)
‪1.01 M‬ INR

About Emcure Pharmaceuticals Limited


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Satish Ramanlal Mehta
Website
emcure.com
Headquarters
Pune
Founded
1981
ISIN
INE168P01015
FIGI
BBG004SL4F06
Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. It focuses on therapeutic areas, such as the gynecology, cardiovascular, Vitamins, minerals and nutrients, Anti-invectives, gastrointestinal, blood related oncology/anti-neoplastics, HIV, neurology, respiratory and anti-diabetic therapeutic areas. The company offers a wide range of products and services under Formulations, Biologics and Active Pharmaceutical Ingredients. It produces pharmaceutical and biopharmaceutical products of a range of dosage forms, including oral solids, oral liquids, injectables including lipid, liposomal, lyophilized injectables, biologics, vaccines and complex APIs, including chiral molecules and cytotoxic products. Emcure Pharmaceuticals was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.

Check out other big names from the same industry as EMCURE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EMCURE news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EMCURE is 1,329.90 INR — it has increased by 0.37% in the past 24 hours. Watch Emcure Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Emcure Pharmaceuticals Limited stocks are traded under the ticker EMCURE.
EMCURE stock has fallen by −2.92% compared to the previous week, the month change is a −11.37% fall, over the last year Emcure Pharmaceuticals Limited has showed a −7.93% decrease.
We've gathered analysts' opinions on Emcure Pharmaceuticals Limited future price: according to them, EMCURE price has a max estimate of 1,740.00 INR and a min estimate of 1,550.00 INR. Watch EMCURE chart and read a more detailed Emcure Pharmaceuticals Limited stock forecast: see what analysts think of Emcure Pharmaceuticals Limited and suggest that you do with its stocks.
EMCURE reached its all-time high on Sep 18, 2024 with the price of 1,580.00 INR, and its all-time low was 889.00 INR and was reached on Apr 7, 2025. View more price dynamics on EMCURE chart.
See other stocks reaching their highest and lowest prices.
EMCURE stock is 1.87% volatile and has beta coefficient of 1.33. Track Emcure Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Emcure Pharmaceuticals Limited there?
Today Emcure Pharmaceuticals Limited has the market capitalization of ‪251.18 B‬, it has decreased by −1.60% over the last week.
Yes, you can track Emcure Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Emcure Pharmaceuticals Limited is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
EMCURE net income for the last quarter is ‪2.07 B‬ INR, while the quarter before that showed ‪1.89 B‬ INR of net income which accounts for 9.52% change. Track more Emcure Pharmaceuticals Limited financial stats to get the full picture.
Yes, EMCURE dividends are paid annually. The last dividend per share was 3.00 INR. As of today, Dividend Yield (TTM)% is 0.23%. Tracking Emcure Pharmaceuticals Limited dividends might help you take more informed decisions.
As of Sep 25, 2025, the company has ‪6.73 K‬ employees. See our rating of the largest employees — is Emcure Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Emcure Pharmaceuticals Limited EBITDA is ‪15.36 B‬ INR, and current EBITDA margin is 17.95%. See more stats in Emcure Pharmaceuticals Limited financial statements.
Like other stocks, EMCURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Emcure Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Emcure Pharmaceuticals Limited technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Emcure Pharmaceuticals Limited stock shows the buy signal. See more of Emcure Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.